Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01795573
77:80:treatment,77:94:cancer,77:95:cancer,104:113:treatment,263:265:treatment,321:352:treatment,334:352:treatment,445:465:treatment
NHL: No clinical evidence of disease or disease-related symptoms; Typically FDG-avid lymphomas: a post-treatment residual mass of any size is permitted as long as it is PET negative; Variably FDG-avid lymphoma/FDG avidity unknown: all lymph nodes normal size by CT; Spleen and liver non-palpable and without nodules; If pretreatment bone marrow biopsy was positive, repeat bone marrow biopsy must be negative; if morphologically indeterminate, immunohistochemistry should be negative If pretreatment bone marrow biopsy was positive, repeat bone marrow biopsy must be negative; if morphologically indeterminate, immunohistochemistry should be negative
1
[ "NHL", ":", "No", "clinical", "evidence", "of", "disease", "or", "disease-related", "symptoms", ";", "Typically", "FDG-avid", "lymphomas", ":", "a", "post-treatment", "residual", "mass", "of", "any", "size", "is", "permitted", "as", "long", "as", "it", "is", "PET", "negative", ";", "Variably", "FDG-avid", "lymphoma/FDG", "avidity", "unknown", ":", "all", "lymph", "nodes", "normal", "size", "by", "CT", ";", "Spleen", "and", "liver", "non-palpable", "and", "without", "nodules", ";", "If", "pretreatment", "bone", "marrow", "biopsy", "was", "positive", ",", "repeat", "bone", "marrow", "biopsy", "must", "be", "negative", ";", "if", "morphologically", "indeterminate", ",", "immunohistochemistry", "should", "be", "negative", "If", "pretreatment", "bone", "marrow", "biopsy", "was", "positive", ",", "repeat", "bone", "marrow", "biopsy", "must", "be", "negative", ";", "if", "morphologically", "indeterminate", ",", "immunohistochemistry", "should", "be", "negative" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01553942
7:23:treatment
Prior EGFR TKI therapy
1
[ "Prior", "EGFR", "TKI", "therapy" ]
[ 0, 1, 1, 1 ]
NCT03078153
1:4:chronic_disease
HIV negative
1
[ "HIV", "negative" ]
[ 2, 0 ]
NCT02128100
71:81:cancer
A reasonable attempt should be made to make a pathologic diagnosis of malignancy
1
[ "A", "reasonable", "attempt", "should", "be", "made", "to", "make", "a", "pathologic", "diagnosis", "of", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02762266
11:41:cancer
Confirmed hepatocellular carcinoma (HCC)
1
[ "Confirmed", "hepatocellular", "carcinoma", "(", "HCC", ")" ]
[ 0, 3, 3, 3, 0, 0 ]
NCT01827384
15:24:treatment,33:69:cancer,57:60:cancer,70:100:cancer,96:99:cancer,158:197:treatment,201:244:treatment
Patients with treatment-related acute myeloid leukemia (AML) (t-AML)/myelodysplastic syndrome (MDS), or with features suggestive of AML/MDS, or who have had prior allogeneic bone marrow transplant or double umbilical cord blood transplantation
1
[ "Patients", "with", "treatment-related", "acute", "myeloid", "leukemia", "(", "AML", ")", "(", "t-AML", ")", "/myelodysplastic", "syndrome", "(", "MDS", ")", ",", "or", "with", "features", "suggestive", "of", "AML/MDS", ",", "or", "who", "have", "had", "prior", "allogeneic", "bone", "marrow", "transplant", "or", "double", "umbilical", "cord", "blood", "transplantation" ]
[ 0, 0, 1, 3, 3, 3, 3, 3, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1 ]
NCT01174108
,,110:114:treatment
ECOG performance status of 3 or more (See Bone & Marrow Transplant Consortium Supportive Care Guidelines for HSCT Recipients)
1
[ "ECOG", "performance", "status", "of", "3", "or", "more", "(", "See", "Bone", "&", "Marrow", "Transplant", "Consortium", "Supportive", "Care", "Guidelines", "for", "HSCT", "Recipients", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT00911560
,,178:190:treatment
stage 4 with (any age) or without (>18 months old) MYCN amplification, MYCN-amplified stage 3 (unresectable; any age), MYCN-amplified stage 4S, or disease resistant to standard chemotherapy
1
[ "stage", "4", "with", "(", "any", "age", ")", "or", "without", "(", ">", "18", "months", "old", ")", "MYCN", "amplification", ",", "MYCN-amplified", "stage", "3", "(", "unresectable", ";", "any", "age", ")", ",", "MYCN-amplified", "stage", "4S", ",", "or", "disease", "resistant", "to", "standard", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02982564
18:31:cancer,,
Be classified in breast cancer stage grouping 0 to III according to the American Joint Committee on Cancer Classification of Malignant Tumors (TNM) Staging System (2013)
1
[ "Be", "classified", "in", "breast", "cancer", "stage", "grouping", "0", "to", "III", "according", "to", "the", "American", "Joint", "Committee", "on", "Cancer", "Classification", "of", "Malignant", "Tumors", "(", "TNM", ")", "Staging", "System", "(", "2013", ")" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02109627
,,67:79:treatment,129:139:treatment,,187:198:treatment
Pregnant women are excluded from this study because the effect of ficlatuzumab on the developing fetus remains unknown and that cytarabine is a pregnancy risk category D drug with known teratogenic or abortifacient effects
1
[ "Pregnant", "women", "are", "excluded", "from", "this", "study", "because", "the", "effect", "of", "ficlatuzumab", "on", "the", "developing", "fetus", "remains", "unknown", "and", "that", "cytarabine", "is", "a", "pregnancy", "risk", "category", "D", "drug", "with", "known", "teratogenic", "or", "abortifacient", "effects" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT00904046
1:7:chronic_disease
Anemia
1
[ "Anemia" ]
[ 2 ]
NCT02495935
15:24:treatment,80:97:chronic_disease,108:127:chronic_disease,129:142:chronic_disease
Presence of a pacemaker, any metal artifacts in head and trunk, any history of epileptic seizure or severe psychiatric disease (schizophrenia, etc.)
1
[ "Presence", "of", "a", "pacemaker", ",", "any", "metal", "artifacts", "in", "head", "and", "trunk", ",", "any", "history", "of", "epileptic", "seizure", "or", "severe", "psychiatric", "disease", "(", "schizophrenia", ",", "etc", ".", ")" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 0, 2, 0, 0, 0, 0 ]
NCT03058029
12:28:chronic_disease,,,,
History of eating disorders including binge eating (except for mild binge eating)or emesis ≥2/week from any cause Weight change >3% within three(3) months prior to and during the Screening period
1
[ "History", "of", "eating", "disorders", "including", "binge", "eating", "(", "except", "for", "mild", "binge", "eating", ")", "or", "emesis", "≥2/week", "from", "any", "cause", "Weight", "change", ">", "3", "%", "within", "three", "(", "3", ")", "months", "prior", "to", "and", "during", "the", "Screening", "period" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02465060
50:84:treatment
Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy
1
[ "Registration", "to", "Step", "0", "must", "occur", "after", "stopping", "prior", "systemic", "anti-cancer", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02502006
6:35:treatment,17:35:treatment,47:58:treatment,60:69:treatment,71:79:treatment,
Used dietary or herbal supplements containing salicylates, Vitamin E, fish oil, or any other herbal supplements, within 14 days of study drug administration
1
[ "Used", "dietary", "or", "herbal", "supplements", "containing", "salicylates", ",", "Vitamin", "E", ",", "fish", "oil", ",", "or", "any", "other", "herbal", "supplements", ",", "within", "14", "days", "of", "study", "drug", "administration" ]
[ 0, 1, 1, 1, 1, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02148003
53:69:allergy_name
Subjects who have a history of adverse reactions to local anesthetic
1
[ "Subjects", "who", "have", "a", "history", "of", "adverse", "reactions", "to", "local", "anesthetic" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4 ]
NCT02600897
1:25:treatment,31:39:cancer,47:81:treatment
fluorodeoxyglucose (FDG)-avid lymphoma (i.e., positron emission tomography (PET)-positive lymphoma)
1
[ "fluorodeoxyglucose", "(", "FDG", ")", "-avid", "lymphoma", "(", "i.e.", ",", "positron", "emission", "tomography", "(", "PET", ")", "-positive", "lymphoma", ")" ]
[ 1, 1, 0, 0, 0, 3, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT03075826
43:53:cancer
Individuals with a history of a different malignancy
1
[ "Individuals", "with", "a", "history", "of", "a", "different", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02759211
42:57:chronic_disease,59:92:chronic_disease,111:145:chronic_disease,147:185:chronic_disease,187:210:chronic_disease,214:234:chronic_disease,247:250:chronic_disease,252:269:chronic_disease,273:285:chronic_disease,287:311:chronic_disease,313:338:chronic_disease,344:365:chronic_disease
Current self-reported medical history of unstable angina, uncontrolled cardiac dysrhythmias causing symptoms, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus or pulmonary infarction, history of DVT, acute myocarditis or pericarditis, acute systemic infection, uncontrolled hypertension, and uncontrolled diabetes [11]
1
[ "Current", "self-reported", "medical", "history", "of", "unstable", "angina", ",", "uncontrolled", "cardiac", "dysrhythmias", "causing", "symptoms", ",", "symptomatic", "severe", "aortic", "stenosis", ",", "uncontrolled", "symptomatic", "heart", "failure", ",", "acute", "pulmonary", "embolus", "or", "pulmonary", "infarction", ",", "history", "of", "DVT", ",", "acute", "myocarditis", "or", "pericarditis", ",", "acute", "systemic", "infection", ",", "uncontrolled", "hypertension", ",", "and", "uncontrolled", "diabetes", "[", "11", "]" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01827384
15:42:chronic_disease,138:153:treatment,192:217:treatment,240:262:chronic_disease,268:295:chronic_disease
Patients with gastrointestinal conditions that might predispose for drug intolerability or poor drug absorption (e.g., inability to take oral medication or a requirement for IV alimentation, prior surgical procedures affecting absorption, malabsorption syndrome, and active peptic ulcer disease)
1
[ "Patients", "with", "gastrointestinal", "conditions", "that", "might", "predispose", "for", "drug", "intolerability", "or", "poor", "drug", "absorption", "(", "e.g.", ",", "inability", "to", "take", "oral", "medication", "or", "a", "requirement", "for", "IV", "alimentation", ",", "prior", "surgical", "procedures", "affecting", "absorption", ",", "malabsorption", "syndrome", ",", "and", "active", "peptic", "ulcer", "disease", ")" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 2, 0 ]
NCT02112565
,,,,,,101:117:cancer
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 2.5 x ULN; AST/ALT =< 5 x ULN if liver metastasis is present
1
[ "Aspartate", "aminotransferase", "(", "AST", ")", "/alanine", "aminotransferase", "(", "ALT", ")", "=", "<", "2.5", "x", "ULN", ";", "AST/ALT", "=", "<", "5", "x", "ULN", "if", "liver", "metastasis", "is", "present" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0 ]
NCT02110069
1:15:cancer
Tufted angioma
1
[ "Tufted", "angioma" ]
[ 3, 3 ]
NCT01756040
1:32:chronic_disease
Lethal chromosome abnormalities
1
[ "Lethal", "chromosome", "abnormalities" ]
[ 2, 2, 2 ]
NCT02503722
31:53:treatment,57:69:treatment,71:93:treatment,129:143:treatment
Documentation of irreversible surgical sterilization by hysterectomy, bilateral oophorectomy or bilateral salpingectomy but not tubal ligation
1
[ "Documentation", "of", "irreversible", "surgical", "sterilization", "by", "hysterectomy", ",", "bilateral", "oophorectomy", "or", "bilateral", "salpingectomy", "but", "not", "tubal", "ligation" ]
[ 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1 ]
NCT02403193
108:117:treatment
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
1
[ "Subject", "is", "willing", "and", "able", "to", "comply", "with", "the", "protocol", "for", "the", "duration", "of", "the", "study", "including", "undergoing", "treatment", "and", "scheduled", "visits", "and", "examinations", "including", "follow", "up" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01986075
19:22:chronic_disease,,105:132:chronic_disease,302:317:treatment,321:334:treatment
Participants with MDD, with symptom severity that exceeds a HAM-D score of 20, and/or any other current Axis I psychiatric disorder as defined by DSM-V supported by the MINI that in the investigator's judgment are unstable, would be disrupted by study medication, or are likely to require specialized pharmacotherapy or psychotherapy during the study period
1
[ "Participants", "with", "MDD", ",", "with", "symptom", "severity", "that", "exceeds", "a", "HAM-D", "score", "of", "20", ",", "and/or", "any", "other", "current", "Axis", "I", "psychiatric", "disorder", "as", "defined", "by", "DSM-V", "supported", "by", "the", "MINI", "that", "in", "the", "investigator", "'s", "judgment", "are", "unstable", ",", "would", "be", "disrupted", "by", "study", "medication", ",", "or", "are", "likely", "to", "require", "specialized", "pharmacotherapy", "or", "psychotherapy", "during", "the", "study", "period" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT02983240
1:32:chronic_disease,,
Severe fetal growth restriction (EFW < 5%)
1
[ "Severe", "fetal", "growth", "restriction", "(", "EFW", "<", "5", "%", ")" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02531932
28:66:treatment,68:77:treatment,79:91:treatment,93:103:treatment
Patients who have received prior treatment with an mTOR inhibitor (sirolimus, temsirolimus, everolimus)
1
[ "Patients", "who", "have", "received", "prior", "treatment", "with", "an", "mTOR", "inhibitor", "(", "sirolimus", ",", "temsirolimus", ",", "everolimus", ")" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 1, 0, 1, 0, 1, 0 ]
NCT02393690
77:93:chronic_disease,95:116:chronic_disease,118:139:chronic_disease,153:177:chronic_disease,179:203:chronic_disease,205:223:chronic_disease,228:265:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, hepatitis B infection, hepatitis C infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
1
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "hepatitis", "B", "infection", ",", "hepatitis", "C", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01530958
1:18:treatment
Kidney transplant recipients
1
[ "Kidney", "transplant", "recipients" ]
[ 1, 1, 0 ]
NCT02903446
1:21:chronic_disease,,,
Vitamin D deficiency [25(OH) vitamin D level < 20 ng/mL (<49.9 nmol/L)]†
1
[ "Vitamin", "D", "deficiency", "[", "25", "(", "OH", ")", "vitamin", "D", "level", "<", "20", "ng/mL", "(", "<", "49.9", "nmol/L", ")", "]", "†" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02358187
4:17:chronic_disease,19:35:chronic_disease,37:46:chronic_disease,50:69:chronic_disease
No overt cardiac, gastrointestinal, pulmonary or psychiatric disease
1
[ "No", "overt", "cardiac", ",", "gastrointestinal", ",", "pulmonary", "or", "psychiatric", "disease" ]
[ 0, 2, 2, 0, 2, 0, 2, 0, 2, 2 ]
NCT02427581
25:38:cancer,
Evidence of progressive breast cancer within the last 30 days
1
[ "Evidence", "of", "progressive", "breast", "cancer", "within", "the", "last", "30", "days" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0 ]
NCT02312518
18:48:treatment,,87:96:treatment,98:107:treatment,111:120:treatment
Received another investigational device or drug within 30 days of enrollment Received allograft, autograft or xenograft within 30 days of enrollment
1
[ "Received", "another", "investigational", "device", "or", "drug", "within", "30", "days", "of", "enrollment", "Received", "allograft", ",", "autograft", "or", "xenograft", "within", "30", "days", "of", "enrollment" ]
[ 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT01841333
1:18:treatment
azole antifungals
1
[ "azole", "antifungals" ]
[ 1, 1 ]
NCT02106988
1:16:treatment,7:16:treatment,60:72:treatment
Prior radiation to the site of current primary disease, if re-treatment would lead to violation of known radiation dose tolerance limits for that site
1
[ "Prior", "radiation", "to", "the", "site", "of", "current", "primary", "disease", ",", "if", "re-treatment", "would", "lead", "to", "violation", "of", "known", "radiation", "dose", "tolerance", "limits", "for", "that", "site" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02469519
46:61:treatment
Any contraindications to the maternal use of corticosteroids
1
[ "Any", "contraindications", "to", "the", "maternal", "use", "of", "corticosteroids" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01959698
,,,31:36:cancer
Ann Arbor stage I to stage IV DLBCL at the time of relapsed/refractory disease to be eligible
1
[ "Ann", "Arbor", "stage", "I", "to", "stage", "IV", "DLBCL", "at", "the", "time", "of", "relapsed/refractory", "disease", "to", "be", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01444209
45:80:cancer
Pathological or radiographic diagnosis of a pan-invasive pituitary macroadenoma
1
[ "Pathological", "or", "radiographic", "diagnosis", "of", "a", "pan-invasive", "pituitary", "macroadenoma" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 3 ]
NCT02581215
57:83:treatment,87:102:treatment,110:118:treatment,122:133:treatment
Subjects whose disease has progressed after 6 months of last systemic chemotherapy or chemo-radiation in the adjuvant or neoadjuvant setting
1
[ "Subjects", "whose", "disease", "has", "progressed", "after", "6", "months", "of", "last", "systemic", "chemotherapy", "or", "chemo-radiation", "in", "the", "adjuvant", "or", "neoadjuvant", "setting" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 1, 0, 1, 0 ]
NCT02059239
,,,,95:98:treatment
Partial response of >50% reduction in bidirectional area of masses and SUV reduction to <8 in PET avid areas Subjects must have evaluable disease
1
[ "Partial", "response", "of", ">", "50", "%", "reduction", "in", "bidirectional", "area", "of", "masses", "and", "SUV", "reduction", "to", "<", "8", "in", "PET", "avid", "areas", "Subjects", "must", "have", "evaluable", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02095184
37:55:treatment,57:74:treatment,79:96:treatment,115:128:cancer
Patients must not have received any prior chemotherapy, radiation therapy, or endocrine therapy for their current breast cancer
1
[ "Patients", "must", "not", "have", "received", "any", "prior", "chemotherapy", ",", "radiation", "therapy", ",", "or", "endocrine", "therapy", "for", "their", "current", "breast", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 3, 3 ]
NCT02304458
35:50:treatment
Patients requiring daily systemic corticosteroids
1
[ "Patients", "requiring", "daily", "systemic", "corticosteroids" ]
[ 0, 0, 0, 0, 1 ]
NCT02465060
5:18:treatment,20:32:treatment,41:69:treatment,,99:112:treatment,,167:176:treatment
Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed >= 4 weeks prior to start of treatment
1
[ "Any", "prior", "therapy", ",", "radiotherapy", "(", "except", "palliative", "radiation", "therapy", "of", "30", "gray", "[", "Gy", "]", "or", "less", ")", ",", "or", "major", "surgery", "must", "have", "been", "completed", ">", "=", "4", "weeks", "prior", "to", "start", "of", "treatment" ]
[ 0, 1, 1, 0, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02332850
24:34:treatment
inability to take oral medication
1
[ "inability", "to", "take", "oral", "medication" ]
[ 0, 0, 0, 0, 1 ]
NCT02734134
1:18:chronic_disease
Fungal infections
1
[ "Fungal", "infections" ]
[ 2, 2 ]
NCT02474667
,43:67:treatment
Must have a negative serum pregnancy test prior to transplantation
1
[ "Must", "have", "a", "negative", "serum", "pregnancy", "test", "prior", "to", "transplantation" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01465100
13:19:chronic_disease,21:30:chronic_disease,38:54:chronic_disease
Subject has sepsis, pneumonia, other active infection
1
[ "Subject", "has", "sepsis", ",", "pneumonia", ",", "other", "active", "infection" ]
[ 0, 0, 2, 0, 2, 0, 0, 2, 2 ]
NCT02533674
7:51:chronic_disease
Known human immunodeficiency virus (HIV) infection
1
[ "Known", "human", "immunodeficiency", "virus", "(", "HIV", ")", "infection" ]
[ 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02146924
36:51:treatment
Research participant has undergone lymphodepletion
1
[ "Research", "participant", "has", "undergone", "lymphodepletion" ]
[ 0, 0, 0, 0, 1 ]
NCT00412594
13:29:chronic_disease
Presence of active infection
1
[ "Presence", "of", "active", "infection" ]
[ 0, 0, 2, 2 ]
NCT02566304
28:39:treatment,43:65:treatment,,88:98:treatment,131:140:treatment
Patients who have received alemtuzumab or antithymocyte globulin within 8 weeks of the transplant admission. The absence of these therapies in the medical record will serve as documentation that they were not given
1
[ "Patients", "who", "have", "received", "alemtuzumab", "or", "antithymocyte", "globulin", "within", "8", "weeks", "of", "the", "transplant", "admission", ".", "The", "absence", "of", "these", "therapies", "in", "the", "medical", "record", "will", "serve", "as", "documentation", "that", "they", "were", "not", "given" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02050347
5:13:cancer,102:116:treatment,122:148:treatment
Any leukemia specific marker (such as t(9:22) or t(4:11)) documented in the patient's leukemia cells pre transplant on a post transplant evaluation
1
[ "Any", "leukemia", "specific", "marker", "(", "such", "as", "t", "(", "9:22", ")", "or", "t", "(", "4:11", ")", ")", "documented", "in", "the", "patient", "'s", "leukemia", "cells", "pre", "transplant", "on", "a", "post", "transplant", "evaluation" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 1 ]
NCT02181478
6:15:treatment
such treatment may continue until the planned course is completed
1
[ "such", "treatment", "may", "continue", "until", "the", "planned", "course", "is", "completed" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02019641
16:41:chronic_disease,53:88:chronic_disease,90:134:chronic_disease,136:147:chronic_disease,166:187:chronic_disease
A diagnosis of interstitial lung disease, including idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonitis (NSIP), sarcoidosis, or other form of chronic lung fibrosis based on clinical context via clinic note from a pulmonologist
1
[ "A", "diagnosis", "of", "interstitial", "lung", "disease", ",", "including", "idiopathic", "pulmonary", "fibrosis", "(", "IPF", ")", ",", "non-specific", "interstitial", "pneumonitis", "(", "NSIP", ")", ",", "sarcoidosis", ",", "or", "other", "form", "of", "chronic", "lung", "fibrosis", "based", "on", "clinical", "context", "via", "clinic", "note", "from", "a", "pulmonologist" ]
[ 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02988960
57:75:chronic_disease,
Participant must not have an active or prior documented autoimmune disease in the last 2 years
1
[ "Participant", "must", "not", "have", "an", "active", "or", "prior", "documented", "autoimmune", "disease", "in", "the", "last", "2", "years" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02177695
37:39:treatment,43:51:treatment,56:63:treatment,67:72:treatment,
Staging scans with abdominal/pelvic CT or MRI scan and CT scan or x-ray of the chest within 56 days prior to registration
1
[ "Staging", "scans", "with", "abdominal/pelvic", "CT", "or", "MRI", "scan", "and", "CT", "scan", "or", "x-ray", "of", "the", "chest", "within", "56", "days", "prior", "to", "registration" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00703105
59:84:cancer
Patients must have a histologic or cytologic diagnosis of epithelial ovarian cancer
1
[ "Patients", "must", "have", "a", "histologic", "or", "cytologic", "diagnosis", "of", "epithelial", "ovarian", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3 ]
NCT02219555
81:89:chronic_disease
someone who could be considered a vulnerable person, such as an individual with dementia
1
[ "someone", "who", "could", "be", "considered", "a", "vulnerable", "person", ",", "such", "as", "an", "individual", "with", "dementia" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02583893
1:10:treatment,18:26:treatment,28:35:treatment,37:44:treatment
Verapamil (e.g., Calan SR, Isoptin, Verelan)
1
[ "Verapamil", "(", "e.g.", ",", "Calan", "SR", ",", "Isoptin", ",", "Verelan", ")" ]
[ 1, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0 ]
NCT02332928
,67:76:treatment,
willing to use an acceptable method of birth control during study treatment and for 3 months afterwards
1
[ "willing", "to", "use", "an", "acceptable", "method", "of", "birth", "control", "during", "study", "treatment", "and", "for", "3", "months", "afterwards" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02596776
1:25:chronic_disease
congestive heart failure
1
[ "congestive", "heart", "failure" ]
[ 2, 2, 2 ]
NCT02454010
14:48:chronic_disease,50:91:chronic_disease,95:118:chronic_disease
positive for human immunodeficiency virus (HIV), hepatitis B virus surface antigen (HBsAg) or hepatitis C virus (HCV)
1
[ "positive", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")", ",", "hepatitis", "B", "virus", "surface", "antigen", "(", "HBsAg", ")", "or", "hepatitis", "C", "virus", "(", "HCV", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02632721
33:69:treatment
Patients who are candidates for allogeneic stem cell transplantation
1
[ "Patients", "who", "are", "candidates", "for", "allogeneic", "stem", "cell", "transplantation" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT01787409
61:70:treatment
During the Active Monitoring Phase of a study (i.e., active treatment and observation), participants must be willing to return to the consenting institution for follow-up
1
[ "During", "the", "Active", "Monitoring", "Phase", "of", "a", "study", "(", "i.e.", ",", "active", "treatment", "and", "observation", ")", ",", "participants", "must", "be", "willing", "to", "return", "to", "the", "consenting", "institution", "for", "follow-up" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01676259
1:18:chronic_disease
hepatitis B virus
1
[ "hepatitis", "B", "virus" ]
[ 2, 2, 2 ]
NCT03105362
1:25:chronic_disease
epithelial cell disorder
1
[ "epithelial", "cell", "disorder" ]
[ 2, 2, 2 ]
NCT01494662
1:21:chronic_disease,27:47:chronic_disease,51:73:chronic_disease
Active liver disease from autoimmune disorders or sclerosing cholangitis
1
[ "Active", "liver", "disease", "from", "autoimmune", "disorders", "or", "sclerosing", "cholangitis" ]
[ 2, 2, 2, 0, 2, 2, 0, 2, 2 ]
NCT02181478
1:33:cancer
Acute myelogenous leukemia (AML)
1
[ "Acute", "myelogenous", "leukemia", "(", "AML", ")" ]
[ 3, 3, 3, 3, 0, 0 ]
NCT01959204
10:20:treatment,60:66:treatment,,110:133:treatment,134:146:treatment,151:163:treatment,165:186:treatment,195:207:treatment,213:232:treatment,241:250:treatment,285:293:treatment,295:308:treatment,314:323:treatment
Uses any medication known to be an inhibitor or inducer of CYP3A4 within 14 days (for inhibitors such as the azole-antifungal agents voriconazole and ketoconazole, macrolide antibiotics such as erythromycin, and protease inhibitors such as ritonavir) or 28 days (for inducers such as rifampin, carbamazepine, and phenytoin) of dosing with study drug
1
[ "Uses", "any", "medication", "known", "to", "be", "an", "inhibitor", "or", "inducer", "of", "CYP3A4", "within", "14", "days", "(", "for", "inhibitors", "such", "as", "the", "azole-antifungal", "agents", "voriconazole", "and", "ketoconazole", ",", "macrolide", "antibiotics", "such", "as", "erythromycin", ",", "and", "protease", "inhibitors", "such", "as", "ritonavir", ")", "or", "28", "days", "(", "for", "inducers", "such", "as", "rifampin", ",", "carbamazepine", ",", "and", "phenytoin", ")", "of", "dosing", "with", "study", "drug" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 1, 1, 0, 0, 1, 0, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02567227
5:22:chronic_disease,26:44:treatment,56:68:treatment,133:149:chronic_disease,,
Any medical condition or chronic medication use (e.g., neuroleptics) that will compromise safety or affect cognitive functioning or terminal illness with life expectancy less than 12 months
1
[ "Any", "medical", "condition", "or", "chronic", "medication", "use", "(", "e.g.", ",", "neuroleptics", ")", "that", "will", "compromise", "safety", "or", "affect", "cognitive", "functioning", "or", "terminal", "illness", "with", "life", "expectancy", "less", "than", "12", "months" ]
[ 0, 2, 2, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02723266
13:16:chronic_disease,33:51:chronic_disease,53:65:chronic_disease,,,,
at risk for GDM (such as having metabolic syndrome, pre-diabetes, or BMI > 85%; and an A1C < 6.5%)
1
[ "at", "risk", "for", "GDM", "(", "such", "as", "having", "metabolic", "syndrome", ",", "pre-diabetes", ",", "or", "BMI", ">", "85", "%", ";", "and", "an", "A1C", "<", "6.5", "%", ")" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02496208
,,75:87:chronic_disease
Lipase and amylase =< 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
1
[ "Lipase", "and", "amylase", "=", "<", "2.0", "x", "ULN", "and", "no", "radiologic", "or", "clinical", "evidence", "of", "pancreatitis" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02759146
12:24:treatment
Undergoing chemotherapy
1
[ "Undergoing", "chemotherapy" ]
[ 0, 1 ]
NCT02816736
8:25:chronic_disease,
Severe liver dysfunction (Childs-Pugh Class C)
1
[ "Severe", "liver", "dysfunction", "(", "Childs-Pugh", "Class", "C", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT03170349
19:22:treatment
Patient in whom a TEE is contraindicated or screening TEE is unsuccessful
1
[ "Patient", "in", "whom", "a", "TEE", "is", "contraindicated", "or", "screening", "TEE", "is", "unsuccessful" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02453373
1:25:chronic_disease
Ventricular fibrillation
1
[ "Ventricular", "fibrillation" ]
[ 2, 2 ]
NCT01430390
,,,51:75:chronic_disease
New York Heart Association (NYHA) stage III or IV congestive heart failure
1
[ "New", "York", "Heart", "Association", "(", "NYHA", ")", "stage", "III", "or", "IV", "congestive", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02811679
1:38:chronic_disease
psychiatric illness/social situations that would limit compliance with study requirements
1
[ "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02057133
46:83:treatment
For Parts A, B, C, D, E, F, H: Have received prior therapy with a CDK4/6 inhibitor
1
[ "For", "Parts", "A", ",", "B", ",", "C", ",", "D", ",", "E", ",", "F", ",", "H", ":", "Have", "received", "prior", "therapy", "with", "a", "CDK4/6", "inhibitor" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1 ]
NCT00977977
53:75:treatment,115:123:chronic_disease,125:142:chronic_disease,146:158:chronic_disease
evidence of intolerance or toxicity associated with cyclosporine treatment of any duration including irreversible azotemia, liver dysfunction or hypertension
1
[ "evidence", "of", "intolerance", "or", "toxicity", "associated", "with", "cyclosporine", "treatment", "of", "any", "duration", "including", "irreversible", "azotemia", ",", "liver", "dysfunction", "or", "hypertension" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 2 ]
NCT02527421
1:13:treatment
PUVA therapy
1
[ "PUVA", "therapy" ]
[ 1, 1 ]
NCT02169739
7:15:chronic_disease,19:33:chronic_disease,69:81:treatment
Prior cortical or retinal stroke (diagnosed either clinically or by neuroimaging)
1
[ "Prior", "cortical", "or", "retinal", "stroke", "(", "diagnosed", "either", "clinically", "or", "by", "neuroimaging", ")" ]
[ 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02343042
1:10:treatment,12:24:treatment,29:42:treatment,56:74:treatment,,94:98:treatment,104:123:treatment,
Radiation, chemotherapy, or immunotherapy or any other anticancer therapy ≤ 2 weeks prior to C1D1, and radio-immunotherapy within 6 weeks prior to C1D1
1
[ "Radiation", ",", "chemotherapy", ",", "or", "immunotherapy", "or", "any", "other", "anticancer", "therapy", "≤", "2", "weeks", "prior", "to", "C1D1", ",", "and", "radio-immunotherapy", "within", "6", "weeks", "prior", "to", "C1D1" ]
[ 1, 0, 1, 0, 0, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT02424968
7:17:cancer
Prior malignancy
1
[ "Prior", "malignancy" ]
[ 0, 3 ]
NCT02931110
1:29:treatment
low-molecular-weight heparin
1
[ "low-molecular-weight", "heparin" ]
[ 1, 1 ]
NCT03088072
1:37:treatment
LAA closure with the WATCHMAN device is planned
1
[ "LAA", "closure", "with", "the", "WATCHMAN", "device", "is", "planned" ]
[ 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02366481
28:31:allergy_name
Subjects with a history of soy allergy
1
[ "Subjects", "with", "a", "history", "of", "soy", "allergy" ]
[ 0, 0, 0, 0, 0, 4, 0 ]
NCT02523443
21:38:allergy_name,59:77:chronic_disease,79:104:chronic_disease,106:141:chronic_disease,143:165:chronic_disease,171:188:chronic_disease,191:215:chronic_disease,217:235:chronic_disease,237:268:chronic_disease,272:315:chronic_disease,318:348:treatment,352:374:chronic_disease,397:411:treatment,499:525:chronic_disease,,,,,,,
Contraindication to epidural catheter placement including bleeding diathesis (essential thrombocythemia, idiopathic thrombocytopenic purpura, von Willebrand disease, and hemophilia A or B), neurological dysfunction (multiple sclerosis, subacute myelo-opticoneuropathy or preexisting lower limb neurological deficit), prior extensive spinal surgery or major spinal deformity, pre-operative use of anti-coagulant with planned use of therapeutic dose of anti-coagulant in post-operatively, documented pre-operative coagulopathy (INR greater than 1.3 not on Coumadin or PTT greater than 42), platelets less than 100,000/μL, or evidence of infection at potential epidural site
1
[ "Contraindication", "to", "epidural", "catheter", "placement", "including", "bleeding", "diathesis", "(", "essential", "thrombocythemia", ",", "idiopathic", "thrombocytopenic", "purpura", ",", "von", "Willebrand", "disease", ",", "and", "hemophilia", "A", "or", "B", ")", ",", "neurological", "dysfunction", "(", "multiple", "sclerosis", ",", "subacute", "myelo-opticoneuropathy", "or", "preexisting", "lower", "limb", "neurological", "deficit", ")", ",", "prior", "extensive", "spinal", "surgery", "or", "major", "spinal", "deformity", ",", "pre-operative", "use", "of", "anti-coagulant", "with", "planned", "use", "of", "therapeutic", "dose", "of", "anti-coagulant", "in", "post-operatively", ",", "documented", "pre-operative", "coagulopathy", "(", "INR", "greater", "than", "1.3", "not", "on", "Coumadin", "or", "PTT", "greater", "than", "42", ")", ",", "platelets", "less", "than", "100,000/μL", ",", "or", "evidence", "of", "infection", "at", "potential", "epidural", "site" ]
[ 0, 0, 4, 4, 0, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 2, 2, 0, 0, 1, 1, 1, 1, 0, 2, 2, 2, 0, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00788164
1:27:chronic_disease
Human papillomavirus (HPV) 16-positive disease by PCR
1
[ "Human", "papillomavirus", "(", "HPV", ")", "16-positive", "disease", "by", "PCR" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03088033
,,53:55:chronic_disease
Tricuspid valve regurgitation defined as grade > 2+ TR
1
[ "Tricuspid", "valve", "regurgitation", "defined", "as", "grade", ">", "2+", "TR" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02564796
26:40:chronic_disease
Infants with significant co-morbidities
1
[ "Infants", "with", "significant", "co-morbidities" ]
[ 0, 0, 0, 2 ]
NCT02263274
17:39:chronic_disease,50:61:cancer,63:88:chronic_disease,90:112:chronic_disease,114:138:treatment,154:169:chronic_disease
Space occupying intracranial pathology including brain tumor, ateriovenous malformation, cavernous malformation, prior surgical resection or significant encephalomalcia that would create unknown tissue inhomogeneity that cannot be accurately modeled
1
[ "Space", "occupying", "intracranial", "pathology", "including", "brain", "tumor", ",", "ateriovenous", "malformation", ",", "cavernous", "malformation", ",", "prior", "surgical", "resection", "or", "significant", "encephalomalcia", "that", "would", "create", "unknown", "tissue", "inhomogeneity", "that", "can", "not", "be", "accurately", "modeled" ]
[ 0, 0, 2, 2, 0, 3, 3, 0, 2, 2, 0, 2, 2, 0, 1, 1, 1, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03077243
1:7:treatment,15:38:cancer,47:50:chronic_disease
Biopsy proven squamous cell carcinoma that is HPV and/or p16 positive
1
[ "Biopsy", "proven", "squamous", "cell", "carcinoma", "that", "is", "HPV", "and/or", "p16", "positive" ]
[ 1, 0, 3, 3, 3, 0, 0, 2, 0, 0, 0 ]
NCT03049189
27:31:allergy_name,33:45:allergy_name,54:78:allergy_name,82:92:allergy_name,96:126:allergy_name
Known hypersensitivity to DOTA, lutetium-177, or any excipient of edotreotide or everolimus or any other Rapamycin derivative
1
[ "Known", "hypersensitivity", "to", "DOTA", ",", "lutetium-177", ",", "or", "any", "excipient", "of", "edotreotide", "or", "everolimus", "or", "any", "other", "Rapamycin", "derivative" ]
[ 0, 0, 0, 4, 0, 4, 0, 0, 4, 4, 4, 4, 0, 4, 0, 0, 0, 0, 0 ]
NCT02516813
104:115:treatment,119:137:treatment,171:186:treatment,187:194:treatment,198:205:treatment,,260:265:treatment,,344:381:treatment,
Subjects currently receiving (or unable to stop using prior to receiving the first dose of trial drug) medications or herbal supplements known to be potent inhibitors of cytochrome P450 (CYP)3A or CYP2C19 (must stop at least 1 week prior), potent inducers of CYP3A or CYP2C19 (must stop at least 3 weeks prior), or drugs mainly metabolized by CYP3A with a narrow therapeutic index (must stop at least one day prior)
1
[ "Subjects", "currently", "receiving", "(", "or", "unable", "to", "stop", "using", "prior", "to", "receiving", "the", "first", "dose", "of", "trial", "drug", ")", "medications", "or", "herbal", "supplements", "known", "to", "be", "potent", "inhibitors", "of", "cytochrome", "P450", "(", "CYP", ")", "3A", "or", "CYP2C19", "(", "must", "stop", "at", "least", "1", "week", "prior", ")", ",", "potent", "inducers", "of", "CYP3A", "or", "CYP2C19", "(", "must", "stop", "at", "least", "3", "weeks", "prior", ")", ",", "or", "drugs", "mainly", "metabolized", "by", "CYP3A", "with", "a", "narrow", "therapeutic", "index", "(", "must", "stop", "at", "least", "one", "day", "prior", ")" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT01595529
1:11:chronic_disease
flank pain
1
[ "flank", "pain" ]
[ 2, 2 ]
NCT01666665
35:48:chronic_disease
Previous diagnosis (pre -burn) of renal failure
1
[ "Previous", "diagnosis", "(", "pre", "-burn", ")", "of", "renal", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02349867
,,,121:130:treatment
Women of childbearing potential must have a negative serum pregnancy test performed within 7 days prior to the start of treatment
1
[ "Women", "of", "childbearing", "potential", "must", "have", "a", "negative", "serum", "pregnancy", "test", "performed", "within", "7", "days", "prior", "to", "the", "start", "of", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02427841
4:17:treatment,22:39:cancer,51:63:treatment,65:82:treatment,95:102:treatment,106:129:treatment
No prior therapy for pancreatic cancer, including chemotherapy, radiation therapy, definitive surgery or investigational therapy
1
[ "No", "prior", "therapy", "for", "pancreatic", "cancer", ",", "including", "chemotherapy", ",", "radiation", "therapy", ",", "definitive", "surgery", "or", "investigational", "therapy" ]
[ 0, 1, 1, 0, 3, 3, 0, 0, 1, 0, 1, 1, 0, 0, 1, 0, 1, 1 ]